OPAT: proof of concept in a peripheral Belgian hospital after review of the literature

References

• Antoniskis A, Anderson BC, Vanvolkinburg EJ, et al. Feasibility of outpatient self-administration of parenteral antibiotics. West J Med. 1978;128(3):203–206.
   PubMedGoogle Scholar
• Seaton RA, Barr DA. Outpatient parenteral antibiotic therapy: principles and practice. Eur J Intern Med. 2013;24(7):617–623.10.1016/j.ejim.2013.03.014
   PubMed Web of Science ®Google Scholar
• Pajarón M, Fernández-Miera MF, Allende I, et al. Self-administered outpatient parenteral antimicrobial therapy (S-OPAT) for infective endocarditis: a safe and effective model. Eur J Intern Med. 2015;26(2):131–136.10.1016/j.ejim.2015.01.001
   PubMed Web of Science ®Google Scholar
• Esposito S, Leone S, Noviello S, et al. Outpatient parenteral antibiotic therapy in the elderly: an Italian observational multicenter study. J Chemother. 2009;21(2):193–198.10.1179/joc.2009.21.2.193
   PubMed Web of Science ®Google Scholar
• Lacroix A, Revest M, Patrat-Delon S, et al. Outpatient parenteral antimicrobial therapy for infective endocarditis: a cost-effective strategy. Med Mal Infect. 2014;44(7):327–330.10.1016/j.medmal.2014.05.001
   PubMed Web of Science ®Google Scholar
• Postema CA. Home treatment and reimbursement in The Netherlands. Int J Antimicrob Agents. 1995;5(1):39–43.10.1016/0924-8579(94)00055-Y
   PubMed Web of Science ®Google Scholar
• Muldoon EG, Allison GM, Gallagher D, et al. Outpatient parenteral antimicrobial therapy (OPAT) in the republic of Ireland: results of a national survey. Eur J Clin Microbiol Infect Dis. 2013;32(11):1465–1470.10.1007/s10096-013-1899-4
   PubMed Web of Science ®Google Scholar
• Lopardo G. Management of endocarditis: outpatient parenteral antibiotic treatment in Argentina. Chemotherapy. 2001;47(Suppl 1):24–32.10.1159/000048565
   PubMed Web of Science ®Google Scholar
• Subedi S, Looke DF, McDougall DA, et al. Supervised self-administration of outpatient parenteral antibiotic therapy: a report from a large tertiary hospital in Australia. Int J Infect Dis. 2015;30:161–165.10.1016/j.ijid.2014.11.021
   PubMed Web of Science ®Google Scholar
• Goodfellow AF, Wai AO, Frighetto L, et al. Quality-of-life assessment in an outpatient parenteral antibiotic program. Ann Pharmacother. 2002;36(12):1851–1855.10.1345/aph.1C153
   PubMed Web of Science ®Google Scholar
• Seetoh T, Lye DC, Cook AR, et al. An outcomes analysis of outpatient parenteral antibiotic therapy (OPAT) in a large Asian cohort. Int J Antimicrob Agents. 2013;41(6):569–573.10.1016/j.ijantimicag.2013.01.015
   PubMed Web of Science ®Google Scholar
• Caplan GA, Ward JA, Brennan NJ, et al. Hospital in the home: a randomised controlled trial. Med J Aust. 1999;170(4):156–160.
   PubMed Web of Science ®Google Scholar
• Corwin P, Toop L, McGeoch G, et al. Randomised controlled trial of intravenous antibiotic treatment for cellulitis at home compared with hospital. BMJ. 2005;330(7483):129.10.1136/bmj.38309.447975.EB
   PubMedGoogle Scholar
• Seaton RA, Sharp E, Bezlyak V, et al. Factors associated with outcome and duration of therapy in outpatient parenteral antibiotic therapy (OPAT) patients with skin and soft-tissue infections. Int J Antimicrob Agents. 2011;38(3):243–248.10.1016/j.ijantimicag.2011.05.008
   PubMed Web of Science ®Google Scholar
• Lillie PJ, Andrews D, Eaves K, et al. Baseline factors predicting the duration of intravenous antibiotic therapy for cellulitis in an outpatient setting. Eur J Clin Microbiol Infect Dis. 2010;29(3):347–349.10.1007/s10096-009-0855-9
   PubMed Web of Science ®Google Scholar
• Garrett T, Harbort Y, Trebble M, et al. Once or twice-daily, algorithm-based intravenous cephazolin for home-based cellulitis treatment. Emerg Med Australas. 2012;24(4):383–392.10.1111/emm.2012.24.issue-4
   PubMed Web of Science ®Google Scholar
• Donald M, Marlow N, Swinburn E, et al. Emergency department management of home intravenous antibiotic therapy for cellulitis. Emerg Med J. 2005;22(10):715–717.10.1136/emj.2004.018143
   PubMed Web of Science ®Google Scholar
• Tice AD, Hoaglund PA, Shoultz DA. Risk factors and treatment outcomes in osteomyelitis. J Antimicrob Chemother. 2003;51(5):1261–1268.10.1093/jac/dkg186
   PubMed Web of Science ®Google Scholar
• Mackintosh CL, White HA, Seaton RA. Outpatient parenteral antibiotic therapy (OPAT) for bone and joint infections: experience from a UK teaching hospital-based service. J Antimicrob Chemother. 2011;66(2):408–415.10.1093/jac/dkq445
   PubMed Web of Science ®Google Scholar
• Duggal A, Barsoum W, Schmitt SK. Patients with prosthetic joint infection on IV antibiotics are at high risk for readmission. Clin Orthop Relat Res. 2009;467(7):1727–1731.10.1007/s11999-009-0825-7
   PubMed Web of Science ®Google Scholar
• White HA, Davis JS, Kittler P, et al. Outpatient parenteral antimicrobial therapy-treated bone and joint infections in a tropical setting. Intern Med J. 2011;41(9):668–673.10.1111/j.1445-5994.2009.02136.x
   PubMed Web of Science ®Google Scholar
• Esposito S, Leone S, Noviello S, et al. Outpatient parenteral antibiotic therapy for bone and joint infections: an Italian multicenter study. J Chemother. 2007;19(4):417–422.10.1179/joc.2007.19.4.417
   PubMed Web of Science ®Google Scholar
• Amodeo MR, Clulow T, Lainchbury J, et al. Outpatient intravenous treatment for infective endocarditis: Safety, effectiveness and one-year outcomes. J Infect. 2009;59(6):387–393.10.1016/j.jinf.2009.09.009
   PubMed Web of Science ®Google Scholar
• Andrews MM, von Reyn CF. Patient selection criteria and management guidelines for outpatient parenteral antibiotic therapy for native valve infective endocarditis. Clin Infect Dis. 2001;33(2):203–209.10.1086/cid.2001.33.issue-2
   PubMed Web of Science ®Google Scholar
• Cervera C, del Río AnaRA, García L, et al. Efficacy and safety of outpatient parenteral antibiotic therapy for infective endocarditis: a ten-year prospective study. Enferm Infecc Microbiol Clin. 2011;29(8):587–592.10.1016/j.eimc.2011.05.007
   PubMed Web of Science ®Google Scholar
• Duncan CJ, Barr DA, Ho A, et al. Risk factors for failure of outpatient parenteral antibiotic therapy (OPAT) in infective endocarditis. J Antimicrob Chemother. 2013;68(7):1650–1654.10.1093/jac/dkt046
   PubMed Web of Science ®Google Scholar
• Htin AK, Friedman ND, Hughes A, et al. Outpatient parenteral antimicrobial therapy is safe and effective for the treatment of infective endocarditis: a retrospective cohort study. Intern Med J. 2013;43(6):700–705.10.1111/imj.2013.43.issue-6
   PubMed Web of Science ®Google Scholar
• McMahon JH, O’keeffe JM, Grayson ML. Is hospital-in-the-home (HITH) treatment of bacterial endocarditis safe and effective? Scand J Infect Dis. 2008;40(1):40–43.10.1080/00365540701522942
   PubMed Web of Science ®Google Scholar
• Partridge DG, O’Brien E, Chapman AL. Outpatient parenteral antibiotic therapy for infective endocarditis: a review of 4 years’ experience at a UK centre. Postgrad Med J. 1041;2012(88):377–381.
   Google Scholar
• Darley ES, Bowker KE, Lovering AM, et al. Use of meropenem 3 g once daily for outpatient treatment of infective exacerbations of bronchiectasis. J Antimicrob Chemother. 2000;45(2):247–250.10.1093/jac/45.2.247
   PubMed Web of Science ®Google Scholar
• Zhou J, Sulaiman Z, Llorin RM, et al. Pharmacokinetics of ertapenem in outpatients with complicated urinary tract infections. J Antimicrob Chemother. 2014;69(9):2517–2521.10.1093/jac/dku143
   PubMed Web of Science ®Google Scholar
• Paladino JA, Poretz D. Outpatient parenteral antimicrobial therapy today. Clin Infect Dis. 2010;51(Suppl 2):S198–S208.10.1086/653594
   PubMedGoogle Scholar
• Nathwani D, Tice A. Ambulatory antimicrobial use: the value of an outcomes registry. J Antimicrob Chemother. 2002;49(1):149–154.10.1093/jac/49.1.149
   PubMed Web of Science ®Google Scholar
• Barr DA, Semple L, Seaton RA. Outpatient parenteral antimicrobial therapy (OPAT) in a teaching hospital-based practice: a retrospective cohort study describing experience and evolution over 10 years. Int J Antimicrob Agents. 2012;39(5):407–413.10.1016/j.ijantimicag.2012.01.016
   PubMed Web of Science ®Google Scholar
• Chapman AL, Dixon S, Andrews D, et al. Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective. J Antimicrob Chemother. 2009;64(6):1316–1324.10.1093/jac/dkp343
   PubMed Web of Science ®Google Scholar
• Hitchcock J, Jepson AP, Main J, et al. Establishment of an outpatient and home parenteral antimicrobial therapy service at a London teaching hospital: a case series. J Antimicrob Chemother. 2009;64(3):630–634.10.1093/jac/dkp212
   PubMed Web of Science ®Google Scholar
• Kieran J, O’Reilly A, Parker J, et al. Self-administered outpatient parenteral antimicrobial therapy: a report of three years experience in the Irish healthcare setting. Eur J Clin Microbiol Infect Dis. 2009;28(11):1369–1374.10.1007/s10096-009-0794-5
   PubMed Web of Science ®Google Scholar
• Yan YM, Singh M, Tonks K, et al. Delivering outpatient antibiotic therapy (OPAT) in an Acute Medical Unit. Acute Med. 2011;10(1):22–25.
   PubMedGoogle Scholar
• Upton A, Ellis-Pegler RB, Woodhouse A. Outpatient Parenteral Antimicrobial Therapy (OPAT): a review of experience at Auckland Hospital. N Z Med J. 2004;117(1200):U1020.
   PubMedGoogle Scholar
• Baharoon S, Almodaimeg H, Al WH, et al. Home intravenous antibiotics in a tertiary care hospital in Saudi Arabia. Ann Saudi Med. 2011;31(5):457–461.10.4103/0256-4947.84621
   PubMed Web of Science ®Google Scholar
• Nathwani D, Morrison J, Seaton RA, et al. Out-patient and home-parenteral antibiotic therapy (OHPAT): evaluation of the impact of one year’s experience in Tayside. Health Bull (Edinb). 1999;57(5):332–337.
   PubMedGoogle Scholar
• MacKenzie M, Rae N, Nathwani D. Outcomes from global adult outpatient parenteral antimicrobial therapy programmes: A review of the last decade. Int J Antimicrob Agents. 2014;43(1):7–16.10.1016/j.ijantimicag.2013.09.006
   PubMed Web of Science ®Google Scholar
• Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015;132(15):1435–1486.10.1161/CIR.0000000000000296
   PubMed Web of Science ®Google Scholar
• Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC)Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36(44):3075–3128.10.1093/eurheartj/ehv319
   PubMed Web of Science ®Google Scholar
• Osmon DR, Berbari EF, Berendt AR, et al. Executive summary: diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2013;56(1):1–10.10.1093/cid/cis966
   PubMed Web of Science ®Google Scholar
• Tice AD, Rehm SJ, Dalovisio JR, et al. Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines. Clin Infect Dis. 2004;38(12):1651–1671.10.1086/420939
   PubMed Web of Science ®Google Scholar
• White B, Seaton RA, Evans TJ. Management of suspected Lyme borreliosis: experience from an outpatient parenteral antibiotic therapy service. QJM. 2013;106(2):133–138.10.1093/qjmed/hcs189
   PubMed Web of Science ®Google Scholar
• Torok ME, Chapman AL, Lessing MP, et al. Outpatient parenteral antimicrobial therapy: recent developments and future prospects. Curr Opin Investig Drugs. 2010;11(8):929–939.
   PubMedGoogle Scholar
• Seaton RA, Morrison J, Man I, et al. Out-patient parenteral antimicrobial therapy–a viable option for the management of cutaneous leishmaniasis. QJM. 1999;92(11):659–667.10.1093/qjmed/92.11.659
   PubMedGoogle Scholar
• Patel S, Abrahamson E, Goldring S, et al. Good practice recommendations for paediatric outpatient parenteral antibiotic therapy (p-OPAT) in the UK: a consensus statement. J Antimicrob Chemother. 2015;70(2):360–373.10.1093/jac/dku401
   PubMed Web of Science ®Google Scholar
• Chapman AL, Seaton RA, Cooper MA, et al. Good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults in the UK: a consensus statement. J Antimicrob Chemother. 2012;67(5):1053–1062.10.1093/jac/dks003
   PubMed Web of Science ®Google Scholar
• Czoski Murray C, Twiddy M, Meads D, et al. Community IntraVenous Antibiotic Study (CIVAS): protokol for an evaluation of patient preferences for and cost-effectivness of community intravenous antibiotic services. BMJ. 2015;5(8):e008965.10.1136/bmjopen-2015-008965
   PubMed Web of Science ®Google Scholar
• Davies KA, Longshaw CM, Davis GL, et al. Underdiagnosis of Clostridium difficile across Europe: the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID). Lancet Infect Dis. 2014;14(12):1208–1219.10.1016/S1473-3099(14)70991-0
   PubMed Web of Science ®Google Scholar
• Madigan T, Banerjee R. Characteristics and outcomes of outpatient parenteral antimicrobial therapy at an academic children’s hospital. Pediatr Infect Dis J. 2013;32(4):346–349.10.1097/INF.0b013e31827ee1c2
   PubMed Web of Science ®Google Scholar
• Chopra V, Flanders SA, Saint S, et al. The Michigan Appropriateness Guide for Intravenous Catheters (MAGIC): Results from a Multispecialty Panel using de RAND/UCLA appropriateness method. Ann Intern Med. 2015;163(6 Suppl):S1–40.10.7326/M15-0744
   PubMed Web of Science ®Google Scholar
• Chopra V, O’Horo JC, Rogers MA, et al. The risk of bloodstream infection associated with peripherally inserted central catheters compared with central venous catheters in adults: a systemic review and meta-analysis. Infect Control Hosp Epidemiol. 2013;34(9):908–918.10.1086/671737
   PubMed Web of Science ®Google Scholar
• Zarbock A, Rosenberger P. Risks associated with peripherally inserted central catheters. Lancet. 2013;382(9902):1399–1400.10.1016/S0140-6736(13)62207-2
   PubMedGoogle Scholar
• Matthews PC, Conlon CP, Berendt AR, et al. Outpatient parenteral antimicrobial therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years. J Antimicrob Chemother. 2007;60(2):356–362.10.1093/jac/dkm210
   PubMed Web of Science ®Google Scholar
• Mujal A, Sola J, Hernandez M, et al. Safety and effectiveness of outpatient parenteral antimicrobial therapy in older people. J Antimicrob Chemother. 2016;71(5):1402–1407.
   PubMed Web of Science ®Google Scholar
• Shrestha NK, Shrestha J, Everett A, et al. Vascular access complications during outpatient parenteral antimicrobial therapy at home: a retrospective cohort study. J Antimicrob Chemother. 2016;71(2):506–512.10.1093/jac/dkv344
   PubMed Web of Science ®Google Scholar
• Bhavan KP, Brown LS, Haley RW. Self-administered outpatient antimicrobial infusion by uninsured patients discharged from a safety-net hospital: a propensity-score-balanced retrospective cohort study. PLoS Med. 2015;12(12):e1001922.10.1371/journal.pmed.1001922
   PubMed Web of Science ®Google Scholar
• Carryn S, Couwenbergh N, Tulkens PM. Long-term stability of temocillin in elastomeric pumps for outpatient antibiotic therapy in cystic fibrosis patients. J Antimicrob Chemother. 2010;65(9):2045–2046.10.1093/jac/dkq229
   PubMed Web of Science ®Google Scholar
• Manning L, Wright C, Ingram PR, et al. Continuous infusions of meropenem in ambulatory care: clinical efficacy, safety and stability. PLoS ONE. 2014;9(7):e102023.10.1371/journal.pone.0102023
   PubMed Web of Science ®Google Scholar
• Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. Clin Infect Dis. 2014;59(2):e10–e52.10.1093/cid/ciu296
   PubMed Web of Science ®Google Scholar
• Ingram PR, Cerbe L, Hassell M, et al. Limited role for outpatient parenteral antibiotic therapy for community-acquired pneumonia. Respirology. 2008;13(6):893–896.10.1111/res.2008.13.issue-6
   PubMed Web of Science ®Google Scholar
• Gilchrist M, Franklin BD, Patel JP. An outpatient parenteral antibiotic therapy (OPAT) map to identify risks associated with an OPAT service. J Antimicrob Chemother. 2008;62(1):177–183.10.1093/jac/dkn152
   PubMed Web of Science ®Google Scholar
• Goldenberg RI, Poretz DM, Eron LJ, et al. Intravenous antibiotic-therapy in ambulatory pediatric-patients. Pediatr Infect Dis J. 1984;3(6):514–517.10.1097/00006454-198411000-00006
   Web of Science ®Google Scholar
• Maraqa NF, Gomez MM, Rathore MH. Outpatient parenteral antimicrobial therapy in osteoarticular infections in children. J Pediatr Orthop. 2002;22(4):506–510.
   PubMed Web of Science ®Google Scholar
• Nelson JD. Options for outpatient management of serious infections. Pediatr Infect Dis J. 1992;11(2):175–178.10.1097/00006454-199202000-00037
   PubMed Web of Science ®Google Scholar
• Copley LA. Pediatric musculoskeletal infection: trends and antibiotic recommendations. J Am Acad Orthop Surg. 2009;17(10):618–626.10.5435/00124635-200910000-00004
   PubMed Web of Science ®Google Scholar
• Tice A. The use of outpatient parenteral antimicrobial therapy in the management of osteomyelitis: data from the outpatient parenteral antimicrobial therapy outcomes registries. Chemotherapy. 2001;47(Suppl 1):5–16.10.1159/000048563
   PubMedGoogle Scholar
• Tande AJ, Patel R. Prosthetic joint infection. Clin Microbiol Rev. 2014;27(2):302–345.10.1128/CMR.00111-13
   PubMed Web of Science ®Google Scholar
• Kam AJ, Leal J, Freedman SB. Pediatric cellulitis success of emergency department short-course intravenous antibiotics. Pediatr Emerg Care. 2010;26(3):171–176.10.1097/PEC.0b013e3181d1de08
   PubMed Web of Science ®Google Scholar
• Gouin S, Chevalier I, Gauthier M, et al. Prospective evaluation of the management of moderate to severe cellulitis with parenteral antibiotics at a paediatric day treatment centre. J Paediatr and Child Health. 2008;44(4):214–218.10.1111/j.1440-1754.2007.01236.x
   PubMed Web of Science ®Google Scholar
• Peterson D, McLeod S, Woolfrey K, et al. Predictors of failure of empiric outpatient antibiotic therapy in emergency department patients with uncomplicated cellulitis. Acad Emerg Med. 2014;21(5):526–531.10.1111/acem.12371
   PubMed Web of Science ®Google Scholar
• Jones GR, Cumming DV, Honeywell G, et al. How is income generated by outpatient parenteral antibiotic treatment (OPAT) in the UK? Analysis of payment tariffs for cellulitis. J Antimicrob Chemother. 2015;70(4):1236–1240.
   PubMed Web of Science ®Google Scholar
• White B, Seaton RA. Complicated skin and soft tissue infections: literature review of evidence for and experience with daptomycin. Infect Drug Resist. 2011;4:115–127.
   PubMedGoogle Scholar
• Moran GJ, Abrahamian FM, LoVecchio F, et al. Acute bacterial skin infections: developments since the 2005 Infectious Diseases Society of America (IDSA) guidelines. J Emerg Med. 2013;44(6):e397–e412.10.1016/j.jemermed.2012.11.050
   PubMedGoogle Scholar
• Seaton RA, Sharp E, Bezlyak V, et al. Factors associated with outcome and duration of therapy in outpatient parenteral antibiotic therapy (OPAT) patients with skin and soft-tissue infections. Int J Antimicrob Agents. 2011;38(3):243–248.10.1016/j.ijantimicag.2011.05.008
   PubMed Web of Science ®Google Scholar
• Dore-Bergeron MJ, Gauthier M, Chevalier I, et al. Urinary tract infections in 1- to 3-month-old infants: ambulatory treatment with intravenous antibiotics. Pediatrics. 2009;124(1):16–22.10.1542/peds.2008-2583
   PubMed Web of Science ®Google Scholar
• Bazaz R, Chapman AL, Winstanley TG. Ertapenem administered as outpatient parenteral antibiotic therapy for urinary tract infections caused by extended-spectrum-beta-lactamase-producing Gram-negative organisms. J Antimicrob Chemother. 2010;65(7):1510–1513.10.1093/jac/dkq152
   PubMed Web of Science ®Google Scholar
• Gauthier M, Chevalier I, Sterescu A, et al. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center. Pediatrics. 2004;114(4):e469–e476.10.1542/peds.2004-0421
   PubMed Web of Science ®Google Scholar
• Niv A, Nash M, Peiser J, et al. Outpatient management of acute mastoiditis with periosteitis in children. International Journal of Pediatric Otorhinolaryngology. 1998;46(1–2):9–13.10.1016/S0165-5876(98)00110-4
   PubMed Web of Science ®Google Scholar
• Gross ND, McInnes RJA, Hwang PH. Outpatient intravenous antibiotics for chronic rhinosinusitis. Laryngoscope. 2002;112(10):1758–1761.10.1097/00005537-200210000-00009
   PubMed Web of Science ®Google Scholar
• Bradley JS, Behrendt CE, Arrieta AC, et al. Convalescent phase outpatient parenteral antiinfective therapy for children with complicated appendicitis. Pediatr Infect Dis J. 2001;20(1):19–24.10.1097/00006454-200101000-00005
   PubMed Web of Science ®Google Scholar
• Warner BW, Kulick RM, Stoops MM, et al. An evidenced-based clinical pathway for acute appendicitis decreases hospital duration and cost. J Pediatr Surg. 1998;33(9):1371–1375.10.1016/S0022-3468(98)90010-0
   PubMed Web of Science ®Google Scholar
• Solomkin JS, Mazuski JE, Bradley JS, et al. Diagnosis and management of complicated intra‐abdominal infection in adults and children: guidelines by the surgical infection society and the infectious diseases society of America. Clin Infect Dis. 2010;50(2):133–164.10.1086/648977
   PubMed Web of Science ®Google Scholar
• Morales JO, Snead H. Efficacy and safety of intravenous cefotaxime for treating pneumonia in outpatients. Am J Med. 1994;97:28–33.10.1016/0002-9343(94)90285-2
   PubMed Web of Science ®Google Scholar
• Hooker L, Kohler J. Safety, efficacy, and acceptability of home intravenous therapy administered by parents of pediatric oncology patients. Medical and Pediatric Oncology. 1999;32(6):421–426.10.1002/(ISSN)1096-911X
   PubMedGoogle Scholar
• Gilchrist FJ, Lenney W. A review of the home intravenous antibiotic service available to children with cystic fibrosis. Arch Dis Child. 2009;94(8):647.10.1136/adc.2009.162222
   PubMed Web of Science ®Google Scholar
• Bradley JS, Ching DK, Phillips SE. Outpatient therapy of serious pediatric infections with ceftriaxone. Pediatr Infect Dis J. 1988;7(3):160–164.10.1097/00006454-198803000-00005
   PubMed Web of Science ®Google Scholar
• WALER JA, RATHORE MH. Outpatient management of pediatric bacterial meningitis. Pediatr Infect Dis J. 1995;14(2):89–92.10.1097/00006454-199502000-00001
   PubMed Web of Science ®Google Scholar
• Tice AD, Strait K, Ramey R, et al. Outpatient parenteral antimicrobial therapy for central nervous system infections. Clin Infect Dis. 1999;29(6):1394–1399.10.1086/313503
   PubMed Web of Science ®Google Scholar
• Rehm S, Campion M, Katz DE, et al. Community-based outpatient parenteral antimicrobial therapy (CoPAT) for Staphylococcus aureus bacteraemia with or without infective endocarditis: analysis of the randomized trial comparing daptomycin with standard therapy. J Antimicrob Chemother. 2009;63(5):1034–1042.10.1093/jac/dkp051
   PubMed Web of Science ®Google Scholar
• Plumridge RJ, Rieck AM, Annus TP, et al. Stability of ceftriaxone sodium in polypropylene syringes at -20, 4, and 20 degrees C. Am J Health Syst Pharm. 1996;53(19):2320–2323.
   PubMed Web of Science ®Google Scholar
• Stendal TL, Klem W, Tonnesen HH, et al. Drug stability and pyridine generation in ceftazidime injection stored in an elastomeric infusion device. Am J Health Syst Pharm. 1998;55(7):683–685.
   PubMed Web of Science ®Google Scholar
• Smith DL, Bauer SM, Nicolau DP. Stability of meropenem in polyvinyl chloride bags and an elastomeric infusion device. Am J Health Syst Pharm. 2004;61(16):1682–1685.
   PubMed Web of Science ®Google Scholar
• Moon YS, Chung KC, Chin A, et al. Stability of piperacillin sodium-tazobactam sodium in polypropylene syringes and polyvinyl chloride minibags. Am J Health Syst Pharm. 1995;52(9):999–1001.
   PubMed Web of Science ®Google Scholar